Gyre Therapeutics Stock (NASDAQ: GYRE) stock price, news, charts, stock research, profile.
You can purchase shares of Gyre Therapeutics (NASDAQ:GYRE) through any online brokerage.
Other companies in Gyre Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Upstream Bio (NASDAQ:UPB), Cogent Biosciences (NASDAQ:COGT) and Syndax Pharmaceuticals (NASDAQ:SNDX).
There is no analysis for Gyre Therapeutics to provide a consensus price target.
The stock price for Gyre Therapeutics (NASDAQ: GYRE) is $12 last updated January 2, 2025 at 4:00 PM EST.
There are no upcoming dividends for Gyre Therapeutics.
Gyre Therapeutics’s FY earnings are confirmed for Tuesday, March 25, 2025.
There is no upcoming split for Gyre Therapeutics.
Gyre Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.